Asset Management
Compare Stocks
4 / 10Stock Comparison
HLNE vs ARES vs BN vs APO
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management - Global
HLNE vs ARES vs BN vs APO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management - Global |
| Market Cap | $4.25B | $40.44B | $104.40B | $73.67B |
| Revenue (TTM) | $713M | $6.47B | $77.66B | $30.30B |
| Net Income (TTM) | $206M | $527M | $1.31B | $4.48B |
| Gross Margin | 70.8% | 74.8% | 40.0% | 88.5% |
| Operating Margin | 44.4% | 27.2% | 39.9% | 34.4% |
| Forward P/E | 14.8x | 20.2x | 16.7x | 14.4x |
| Total Debt | $368M | $14.91B | $263.42B | $13.36B |
| Cash & Equiv. | $277M | $1.50B | $16.24B | $19.24B |
HLNE vs ARES vs BN vs APO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Hamilton Lane Incor… (HLNE) | 100 | 121.6 | +21.6% |
| Ares Management Cor… (ARES) | 100 | 326.1 | +226.1% |
| Brookfield Corporat… (BN) | 100 | 273.1 | +173.1% |
| Apollo Global Manag… (APO) | 100 | 268.5 | +168.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HLNE vs ARES vs BN vs APO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HLNE is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 28.7%, EPS growth 46.6%
- Lower volatility, beta 1.25, Low D/E 39.9%, current ratio 1.68x
- Beta 1.25, yield 2.8%, current ratio 1.68x
- Beta 1.25 vs ARES's 1.62, lower leverage
ARES is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 7 yrs, beta 1.62, yield 6.6%
- 9.3% 10Y total return vs APO's 7.6%
- 66.6% NII/revenue growth vs BN's -9.7%
- 6.6% yield, 7-year raise streak, vs HLNE's 2.8%, (1 stock pays no dividend)
BN carries the broadest edge in this set and is the clearest fit for quality and momentum.
- Efficiency ratio 0.0% vs APO's 0.5% (lower = leaner)
- +25.5% vs HLNE's -42.6%
- Efficiency ratio 0.0% vs APO's 0.5%
APO is the clearest fit if your priority is valuation efficiency.
- PEG 0.19 vs ARES's 1.15
- Lower P/E (14.4x vs 20.2x), PEG 0.19 vs 1.15
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 66.6% NII/revenue growth vs BN's -9.7% | |
| Value | Lower P/E (14.4x vs 20.2x), PEG 0.19 vs 1.15 | |
| Quality / Margins | Efficiency ratio 0.0% vs APO's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 1.25 vs ARES's 1.62, lower leverage | |
| Dividends | 6.6% yield, 7-year raise streak, vs HLNE's 2.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +25.5% vs HLNE's -42.6% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs APO's 0.5% |
HLNE vs ARES vs BN vs APO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HLNE vs ARES vs BN vs APO — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HLNE leads in 2 of 6 categories
APO leads 1 • BN leads 1 • ARES leads 1 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HLNE leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BN is the larger business by revenue, generating $77.7B annually — 108.9x HLNE's $713M. HLNE is the more profitable business, keeping 30.5% of every revenue dollar as net income compared to BN's 1.7%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $713M | $6.5B | $77.7B | $30.3B |
| EBITDAEarnings before interest/tax | $320M | $1.8B | $32.1B | $11.5B |
| Net IncomeAfter-tax profit | $206M | $527M | $1.3B | $4.5B |
| Free Cash FlowCash after capex | $364M | $1.5B | -$2.8B | $5.4B |
| Gross MarginGross profit ÷ Revenue | +70.8% | +74.8% | +40.0% | +88.5% |
| Operating MarginEBIT ÷ Revenue | +44.4% | +27.2% | +39.9% | +34.4% |
| Net MarginNet income ÷ Revenue | +30.5% | +8.2% | +1.7% | +14.8% |
| FCF MarginFCF ÷ Revenue | +43.7% | +23.9% | — | +24.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -56.8% | -80.9% | +73.1% | +16.3% |
Valuation Metrics
APO leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 16.4x trailing earnings, HLNE trades at a 100% valuation discount to BN's 9999.0x P/E. Adjusting for growth (PEG ratio), APO offers better value at 0.23x vs ARES's 3.56x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $4.2B | $40.4B | $104.4B | $73.7B |
| Enterprise ValueMkt cap + debt − cash | $4.3B | $53.9B | $351.6B | $67.8B |
| Trailing P/EPrice ÷ TTM EPS | 16.44x | 62.83x | 9999.00x | 17.60x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.77x | 20.23x | 16.69x | 14.42x |
| PEG RatioP/E ÷ EPS growth rate | 0.81x | 3.56x | — | 0.23x |
| EV / EBITDAEnterprise value multiple | 13.31x | 26.88x | 8.53x | 5.92x |
| Price / SalesMarket cap ÷ Revenue | 5.96x | 6.25x | 1.34x | 2.43x |
| Price / BookPrice ÷ Book value/share | 4.60x | 3.08x | 0.66x | 1.83x |
| Price / FCFMarket cap ÷ FCF | 13.64x | 26.19x | — | 9.89x |
Profitability & Efficiency
HLNE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
HLNE delivers a 15.6% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $1 for BN. APO carries lower financial leverage with a 0.31x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARES's 1.71x. On the Piotroski fundamental quality scale (0–9), ARES scores 8/9 vs APO's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.6% | +6.2% | +0.8% | +12.1% |
| ROA (TTM)Return on assets | +9.5% | +1.9% | +0.3% | +1.0% |
| ROICReturn on invested capital | +21.2% | +6.1% | +5.6% | +16.0% |
| ROCEReturn on capital employed | +26.2% | +7.3% | +7.2% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 8 | 5 | 3 |
| Debt / EquityFinancial leverage | 0.40x | 1.71x | 1.59x | 0.31x |
| Net DebtTotal debt minus cash | $91M | $13.4B | $247.2B | -$5.9B |
| Cash & Equiv.Liquid assets | $277M | $1.5B | $16.2B | $19.2B |
| Total DebtShort + long-term debt | $368M | $14.9B | $263.4B | $13.4B |
| Interest CoverageEBIT ÷ Interest expense | 25.57x | 2.68x | 1.64x | 28.98x |
Total Returns (Dividends Reinvested)
BN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARES five years ago would be worth $26,021 today (with dividends reinvested), compared to $10,713 for HLNE. Over the past 12 months, BN leads with a +25.5% total return vs HLNE's -42.6%. The 3-year compound annual growth rate (CAGR) favors BN at 30.5% vs HLNE's 12.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -34.5% | -25.1% | -0.1% | -12.5% |
| 1-Year ReturnPast 12 months | -42.6% | -21.1% | +25.5% | +0.4% |
| 3-Year ReturnCumulative with dividends | +42.4% | +64.7% | +122.1% | +115.8% |
| 5-Year ReturnCumulative with dividends | +7.1% | +160.2% | +89.3% | +135.1% |
| 10-Year ReturnCumulative with dividends | +464.7% | +929.6% | +308.9% | +759.2% |
| CAGR (3Y)Annualised 3-year return | +12.5% | +18.1% | +30.5% | +29.2% |
Risk & Volatility
Evenly matched — HLNE and BN each lead in 1 of 2 comparable metrics.
Risk & Volatility
HLNE is the less volatile stock with a 1.25 beta — it tends to amplify market swings less than ARES's 1.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BN currently trades 93.8% from its 52-week high vs HLNE's 49.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.25x | 1.62x | 1.57x | 1.43x |
| 52-Week HighHighest price in past year | $179.19 | $195.26 | $49.57 | $157.28 |
| 52-Week LowLowest price in past year | $86.47 | $95.80 | $36.47 | $99.56 |
| % of 52W HighCurrent price vs 52-week peak | +49.6% | +63.1% | +93.8% | +81.3% |
| RSI (14)Momentum oscillator 0–100 | 37.3 | 63.2 | 62.5 | 64.9 |
| Avg Volume (50D)Average daily shares traded | 843K | 3.7M | 5.9M | 5.2M |
Analyst Outlook
ARES leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HLNE as "Buy", ARES as "Buy", BN as "Buy", APO as "Buy". Consensus price targets imply 92.8% upside for HLNE (target: $172) vs 17.0% for BN (target: $54). For income investors, ARES offers the higher dividend yield at 6.56% vs APO's 1.67%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $171.50 | $177.38 | $54.40 | $157.25 |
| # AnalystsCovering analysts | 10 | 22 | 9 | 28 |
| Dividend YieldAnnual dividend ÷ price | +2.8% | +6.6% | — | +1.7% |
| Dividend StreakConsecutive years of raises | 1 | 7 | 1 | 3 |
| Dividend / ShareAnnual DPS | $2.51 | $8.08 | — | $2.14 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.0% | 0.0% | 0.0% | +1.0% |
HLNE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). APO leads in 1 (Valuation Metrics). 1 tied.
HLNE vs ARES vs BN vs APO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HLNE or ARES or BN or APO a better buy right now?
For growth investors, Ares Management Corporation (ARES) is the stronger pick with 66.
6% revenue growth year-over-year, versus -9. 7% for Brookfield Corporation (BN). Hamilton Lane Incorporated (HLNE) offers the better valuation at 16. 4x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate Hamilton Lane Incorporated (HLNE) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HLNE or ARES or BN or APO?
On trailing P/E, Hamilton Lane Incorporated (HLNE) is the cheapest at 16.
4x versus Brookfield Corporation at 9999. 0x. On forward P/E, Apollo Global Management, Inc. is actually cheaper at 14. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Apollo Global Management, Inc. wins at 0. 19x versus Ares Management Corporation's 1. 15x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — HLNE or ARES or BN or APO?
Over the past 5 years, Ares Management Corporation (ARES) delivered a total return of +160.
2%, compared to +7. 1% for Hamilton Lane Incorporated (HLNE). Over 10 years, the gap is even starker: ARES returned +929. 6% versus BN's +308. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HLNE or ARES or BN or APO?
By beta (market sensitivity over 5 years), Hamilton Lane Incorporated (HLNE) is the lower-risk stock at 1.
25β versus Ares Management Corporation's 1. 62β — meaning ARES is approximately 29% more volatile than HLNE relative to the S&P 500. On balance sheet safety, Apollo Global Management, Inc. (APO) carries a lower debt/equity ratio of 31% versus 171% for Ares Management Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — HLNE or ARES or BN or APO?
By revenue growth (latest reported year), Ares Management Corporation (ARES) is pulling ahead at 66.
6% versus -9. 7% for Brookfield Corporation (BN). On earnings-per-share growth, the picture is similar: Hamilton Lane Incorporated grew EPS 46. 6% year-over-year, compared to -99. 8% for Brookfield Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HLNE or ARES or BN or APO?
Hamilton Lane Incorporated (HLNE) is the more profitable company, earning 30.
5% net margin versus 1. 7% for Brookfield Corporation — meaning it keeps 30. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLNE leads at 44. 4% versus 27. 2% for ARES. At the gross margin level — before operating expenses — APO leads at 88. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HLNE or ARES or BN or APO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Apollo Global Management, Inc. (APO) is the more undervalued stock at a PEG of 0. 19x versus Ares Management Corporation's 1. 15x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Apollo Global Management, Inc. (APO) trades at 14. 4x forward P/E versus 20. 2x for Ares Management Corporation — 5. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLNE: 92. 8% to $171. 50.
08Which pays a better dividend — HLNE or ARES or BN or APO?
In this comparison, ARES (6.
6% yield), HLNE (2. 8% yield), APO (1. 7% yield) pay a dividend. BN does not pay a meaningful dividend and should not be held primarily for income.
09Is HLNE or ARES or BN or APO better for a retirement portfolio?
For long-horizon retirement investors, Apollo Global Management, Inc.
(APO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 7% yield, +759. 2% 10Y return). Brookfield Corporation (BN) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (APO: +759. 2%, BN: +308. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HLNE and ARES and BN and APO?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HLNE is a small-cap high-growth stock; ARES is a mid-cap high-growth stock; BN is a mid-cap quality compounder stock; APO is a mid-cap high-growth stock. HLNE, ARES, APO pay a dividend while BN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.